PRTA
PROTHENA CORP PUBLIC LTD CO
Key Financials
Revenue
$9.7M
↓ 92.8%
Operating Income
$-214640000
↓ 38.9%
Net Income
$-244092000
↓ 99.6%
Total Liabilities
$46.3M
↓ 23.0%
EPS (Diluted)
$-4.53
↓ 99.6%
Total Assets
$326.8M
↓ 40.3%
Shareholders' Equity
$280.5M
↓ 42.4%
Cash & Equivalents
$307.5M
↓ 34.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 3 | 6/12/2026 | View on SEC |
| 144 | 6/9/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/3/2026 | View on SEC |
| 4 | 5/26/2026 | View on SEC |
| 4 | 5/15/2026 | View on SEC |
| 4 | 5/15/2026 | View on SEC |
| 4 | 5/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PRTA |
| Company Name | PROTHENA CORP PUBLIC LTD CO |
| CIK | 1559053 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | L2 |
| Phone | 011-353-1-236-2500 |